Background: Presbycusis is the most common degenerative otologic condition. New research is pointing toward vascular changes within the cochlea with age. Vascular endothelial growth factor (VEGF) and its receptors, Flt-1 and Flk-1, are important regulators of angiogenesis.
Objective: The aim of this study was to characterize the hearing, VEGF expression, and vasculature of young and old Swiss Webster (SW) mice.
Methods: Young (4 weeks, n = 14) and aged (32-36 weeks; n = 14) SW mice were used. Hearing was evaluated using the auditory brainstem response. Changes in VEGF, Flt-1, and Flk-1 expression and histology were evaluated by immunohistochemistry and real-time polymerase chain reaction (quantitative PCR).
Results: Aged SW mice demonstrated clinically stable hearing with age with mean hearing thresholds dropping 5.7, 4.2, 6.5, and 10.9 dB peSPL with age at 4, 8, 16, and 32 kHz pure-tone stimuli, respectively. Immunohistochemistry showed the presence of VEGF, Flt-1, and Flk-1 in the stria vascularis, spiral ganglion, and organ of Corti. Strong expression was found within the hair cells and the stria vascularis. Immunohistochemistry and qPCR demonstrated no difference in expression levels between age groups or between apical and basal turns of the cochlea. Microscopy demonstrated no difference in the number or density of stria vascularis vessels between age groups.
Conclusions: We describe a mouse model of stable hearing with aging. Stria vascularis vasculature and expression of VEGF, Flt-1, and Flk-1 do not change with age, and there appears to be no apical to basal differential expression. These results provide valuable normalized data to compare VEGF expression and vasculature patterns to other mouse strains.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Endothelial cell-derived extracellular vesicles induce pro-angiogenic responses in mesenchymal stem cells.
FEBS Open Bio
May 2024
Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Yeditepe University, Turkey.
Angiogenesis is a central component of vital biological processes such as wound healing, tissue nourishment, and development. Therefore, angiogenic activities are precisely maintained with secreted factors such as angiopoietin-1 (Ang1), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). As an element of intracellular communication, extracellular vesicles (EVs)-particularly EVs of vascular origin-could have key functions in maintaining angiogenesis.
View Article and Find Full Text PDFEffect of Glucocorticoid Nanoliposomes on Vascular Endothelial Growth Factor Expression in Brain Tissue of Rats with Tuberculous Meningitis.
Cell Mol Biol (Noisy-le-grand)
August 2022
Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
To investigate the effect of human brain-targeted nanoliposomes encapsulating methylprednisolone sodium succinate on the level of vascular endothelial growth factor (VEGF) in brain tissue of rats with tuberculous meningitis (TBM), the nanoliposome DSPE-125I-AIBZM-MPS was prepared. 180 rats were divided into normal control, TBM infection, and TBM treatment groups. The brain water content, Evans blue (EB) content, VEGF, and the gene and protein expression of receptors (Flt-1, Flk-1) of rats after modeling were measured.
View Article and Find Full Text PDFRapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma.
Int J Immunopathol Pharmacol
March 2022
Department of Pathology, School of Medical Sciences, 65271Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
Angiogenesis is the process of new vascular formation, which is derived from various factors. For suppressing cancer cell growth, targeting angiogenesis is one of the therapeutic approaches. Vascular endothelial growth factor family receptors, including Flt-1, Flk-1 and Flt-4, have been found to play an essential role in regulating angiogenesis.
View Article and Find Full Text PDFGene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model.
Microvasc Res
May 2022
Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut School of Medicine, University of Connecticut Health Center, Farmington 06030, CT, USA. Electronic address:
Objectives: In the United States, over 8.5 million people suffer from peripheral arterial disease (PAD). Previously we reported that Pellino-1(Peli1) gene therapy reduces ischemic damage in the myocardium and skin flaps in Flk-1 [Fetal Liver kinase receptor-1 (Flk-1)/ Vascular endothelial growth factor receptor-2/VEGFR2] heterozygous (Flk-1) mice.
View Article and Find Full Text PDFPeroxisome Proliferator-Activated Receptor γ Coactivator 1α Activates Vascular Endothelial Growth Factor That Protects Against Neuronal Cell Death Following Status Epilepticus through PI3K/AKT and MEK/ERK Signaling.
Int J Mol Sci
September 2020
College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Status epilepticus may cause molecular and cellular events, leading to hippocampal neuronal cell death. Peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) is an important regulator of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2), also known as fetal liver kinase receptor 1 (Flk-1). Resveratrol is an activator of PGC-1α.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!